JP2024534550A5 - - Google Patents
Info
- Publication number
- JP2024534550A5 JP2024534550A5 JP2024518167A JP2024518167A JP2024534550A5 JP 2024534550 A5 JP2024534550 A5 JP 2024534550A5 JP 2024518167 A JP2024518167 A JP 2024518167A JP 2024518167 A JP2024518167 A JP 2024518167A JP 2024534550 A5 JP2024534550 A5 JP 2024534550A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody molecule
- pharmaceutical composition
- combination
- composition according
- specifically binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306310 | 2021-09-22 | ||
| EP21306310.0 | 2021-09-22 | ||
| EP22305050.1 | 2022-01-18 | ||
| EP22305050 | 2022-01-18 | ||
| PCT/EP2022/076268 WO2023046777A1 (en) | 2021-09-22 | 2022-09-21 | Novel combinations of antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534550A JP2024534550A (ja) | 2024-09-20 |
| JP2024534550A5 true JP2024534550A5 (cg-RX-API-DMAC10.html) | 2025-09-08 |
Family
ID=83507478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518167A Pending JP2024534550A (ja) | 2021-09-22 | 2022-09-21 | 抗体の新規組み合わせ及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240374719A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4405050A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024534550A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240067076A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022351060A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3231396A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL311234A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024003578A (cg-RX-API-DMAC10.html) |
| TW (1) | TW202321458A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023046777A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2833425T3 (es) * | 2014-07-16 | 2021-06-15 | Roussy Inst Gustave | Combinación de virus oncolítico con moduladores de punto de control inmunitario |
| CN120648657A (zh) * | 2024-03-08 | 2025-09-16 | 上海锦斯生物技术有限公司 | 一种修饰的溶瘤病毒及其组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| RU2489486C2 (ru) | 2006-06-20 | 2013-08-10 | Трансжене С.А. | Процесс получения поксвирусов и композиции поксвирусов |
| EP1985305A1 (en) | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
| AU2008250596C1 (en) | 2007-05-14 | 2010-11-25 | Bavarian Nordic A/S | Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines |
| US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
| DK2212345T3 (en) | 2007-11-19 | 2016-03-21 | Transgene Sa | Oncolytic poxvirus vectors |
| AU2009214768B2 (en) | 2008-02-12 | 2015-01-22 | Sanofi Pasteur Limited | Methods using ion exchange and gel filtration chromatography for poxvirus purification |
| SG176554A1 (en) | 2009-05-12 | 2012-01-30 | Transgene Sa | Method for orthopoxvirus production and purification |
| KR102022952B1 (ko) | 2011-08-05 | 2019-09-20 | 신라젠(주) | 백시니아 바이러스의 생산을 위한 방법 및 조성물 |
| WO2018170133A1 (en) * | 2017-03-15 | 2018-09-20 | Amgen Inc. | Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer |
| CN118892540A (zh) * | 2017-04-21 | 2024-11-05 | 新罗杰股份有限公司 | 溶瘤痘苗病毒与免疫检查点抑制剂联合疗法 |
| WO2019178101A1 (en) * | 2018-03-13 | 2019-09-19 | Memorial Sloan Kettering Cancer Center | Oncolytic vaccinia virus expressing immune checkpoint blockade for cancer immunotherapy |
| EP3617230A1 (en) * | 2018-09-03 | 2020-03-04 | BioInvent International AB | Novel antibodies and nucleotide sequences, and uses thereof |
| TW202102543A (zh) * | 2019-03-29 | 2021-01-16 | 美商安進公司 | 溶瘤病毒在癌症新輔助療法中之用途 |
| CN111763660A (zh) * | 2020-08-07 | 2020-10-13 | 南京大学 | 一种重组溶瘤痘苗病毒及其制备方法和应用 |
-
2022
- 2022-09-20 TW TW111135598A patent/TW202321458A/zh unknown
- 2022-09-21 EP EP22782722.7A patent/EP4405050A1/en active Pending
- 2022-09-21 KR KR1020247010183A patent/KR20240067076A/ko active Pending
- 2022-09-21 US US18/691,186 patent/US20240374719A1/en active Pending
- 2022-09-21 WO PCT/EP2022/076268 patent/WO2023046777A1/en not_active Ceased
- 2022-09-21 IL IL311234A patent/IL311234A/en unknown
- 2022-09-21 AU AU2022351060A patent/AU2022351060A1/en active Pending
- 2022-09-21 MX MX2024003578A patent/MX2024003578A/es unknown
- 2022-09-21 JP JP2024518167A patent/JP2024534550A/ja active Pending
- 2022-09-21 CA CA3231396A patent/CA3231396A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7732977B2 (ja) | Ｈｐｖポリペプチドおよびｉｌ－２をコードするポックスウイルスと抗ｐｄ－ｌ１抗体の組合せ | |
| CN107922503B (zh) | 一种pdl-1抗体、其药物组合物及其用途 | |
| KR101838310B1 (ko) | 암의 치료를 위한 인간화 항-cxcr4 항체들 | |
| JP2022514179A5 (cg-RX-API-DMAC10.html) | ||
| JP2013502913A5 (cg-RX-API-DMAC10.html) | ||
| JP2024531409A5 (cg-RX-API-DMAC10.html) | ||
| JP2020534017A5 (cg-RX-API-DMAC10.html) | ||
| RU2019104980A (ru) | Анти-icos антитела | |
| CN111388664A (zh) | 干细胞增强疗法 | |
| JP2009520733A (ja) | 可溶性ｃｅａに対する抵抗性を有する医薬抗体組成物 | |
| JP2021177770A (ja) | ＣＤ６６ｃに特異的に結合する抗体およびその用途 | |
| CN117050165B (zh) | 一种靶向猴痘病毒的抗体、其抗原结合片段及其用途 | |
| JP2024538148A5 (cg-RX-API-DMAC10.html) | ||
| JPWO2020067085A1 (ja) | 腫瘍溶解性ワクシニアウイルスと免疫チェックポイント阻害剤との併用によるがん療法並びにこれに用いるための医薬組成物及び組合せ医薬 | |
| JP2024540148A5 (cg-RX-API-DMAC10.html) | ||
| CN115925940B (zh) | 特异性结合cd47的抗体、其重组溶瘤病毒及其用途 | |
| JP2024534116A5 (cg-RX-API-DMAC10.html) | ||
| JP2024091656A5 (cg-RX-API-DMAC10.html) | ||
| JP7407742B2 (ja) | Ｇａｓｐ－１顆粒を標的とする結合性タンパク質及びキメラ抗原受容体ｔ細胞並びにそれらの使用 | |
| JP2022512544A5 (cg-RX-API-DMAC10.html) | ||
| Wang et al. | Construction of a novel TROP2/CD3 bispecific antibody with potent antitumor activity and reduced induction of Th1 cytokines | |
| Takahashi et al. | Neural cell adhesion molecule 2 as a target molecule for prostate and breast cancer gene therapy | |
| RU2024110605A (ru) | Новые комбинации антител и их применение | |
| CN114616245B (zh) | 一种抗cd38的抗体及其用途 | |
| RU2824962C1 (ru) | Комбинация поксвируса, кодирующего полипептиды вируса папилломы человека, и il-2 с антителом к pd-l1 |